PTCT icon

PTC Therapeutics
PTCT

Overview Fund Activity

279 hedge funds and large institutions have $3.88B invested in PTC Therapeutics in 2025 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 110 increasing their positions, 81 reducing their positions, and 35 closing their positions.

Holders
279
Holders Change
+18
Holders Change %
+6.9%
% of All Funds
3.75%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
57
Increased
110
Reduced
81
Closed
35
Calls
$6.11M
Puts
$4.37M
Net Calls
+$1.74M
Net Calls Change
-$1.56M

Top Buyers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$119M
2
Bank of America
2
Bank of America
North Carolina
$67.5M
3
Pacer Advisors
3
Pacer Advisors
Pennsylvania
$36.2M
4
HRCM
4
Hood River Capital Management
Florida
$31.1M
5
State Street
5
State Street
Massachusetts
$146M

Top Sellers

1
CCM
1
Camber Capital Management
Massachusetts
$0
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$229M
4
AC
4
Armistice Capital
New York
$231M
5
UBS Group
5
UBS Group
Switzerland
$28.3M
Name Market Value Shares Shares
Change 		Shares
Change %
Man Group
26
Man Group
United Kingdom
$32.8M 671,513 +410,653 +157%
HRCM
27
Hood River Capital Management
Florida
$31.1M 636,502 +552,130 +654%
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$30.8M 631,622 +293,662 +87%
Adage Capital Partners
29
Adage Capital Partners
Massachusetts
$29.6M 605,905 +10,905 +2%
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$29.4M 601,560 -1,922 -0.3%
UBS Group
31
UBS Group
Switzerland
$28.3M 578,950 -690,697 -54%
Marshall Wace
32
Marshall Wace
United Kingdom
$26.3M 537,776 -203,226 -27%
AQR Capital Management
33
AQR Capital Management
Connecticut
$26.2M 537,116 +124,093 +30%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$25.8M 527,404 -34,435 -6%
Rockefeller Capital Management
35
Rockefeller Capital Management
New York
$22.6M 463,079 +7,751 +2%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$22.2M 453,602 -14,952 -3%
MB
37
MPM BioImpact
Massachusetts
$21.4M 438,477 -1,500 -0.3%
PAI
38
Palo Alto Investors
California
$19.9M 406,469 +2,273 +0.6%
Lord, Abbett & Co
39
Lord, Abbett & Co
New Jersey
$18.8M 384,447 +384,447 New
Millennium Management
40
Millennium Management
New York
$18.8M 384,402 +159,563 +71%
SI
41
Sofinnova Investments
California
$18.4M 375,939 -203,400 -35%
Qube Research & Technologies (QRT)
42
Qube Research & Technologies (QRT)
United Kingdom
$16.5M 338,163 +41,596 +14%
Invesco
43
Invesco
Georgia
$14.8M 303,234 -7,095 -2%
Citigroup
44
Citigroup
New York
$14.1M 288,536 -17,281 -6%
PAM
45
Panagora Asset Management
Massachusetts
$14M 286,057 -25,720 -8%
Barclays
46
Barclays
United Kingdom
$13.7M 279,812 +147,473 +111%
TI
47
Trexquant Investment
Connecticut
$13.3M 272,774 +78,975 +41%
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$13.3M 272,339 +270,503 +14,733%
Ensign Peak Advisors
49
Ensign Peak Advisors
Utah
$13.1M 268,217 -6,050 -2%
Bank of New York Mellon
50
Bank of New York Mellon
New York
$13M 266,171 +49,728 +23%
1
2
3 4 5